TYKINERB Trademark

Trademark Overview


On Tuesday, August 5, 2003, a trademark application was filed for TYKINERB with the United States Patent and Trademark Office. The USPTO has given the TYKINERB trademark a serial number of 78283123. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 8, 2011. This trademark is owned by Glaxo Group Limited. The TYKINERB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, [ infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations; Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations ]

General Information


Serial Number78283123
Word MarkTYKINERB
Filing DateTuesday, August 5, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 8, 2011
Registration Number2881663
Registration DateTuesday, September 7, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 15, 2004

Trademark Statements


Amendment to a Registration/Renewal CertificateIn the statement, Column 1, lines 7-18, "infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations; Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflamma-" is deleted. In the statement, Column 2, lines 1-8, "tion, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations" is deleted.
Goods and ServicesPharmaceutical preparations for the treatment of cancer, [ infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations; Pharmaceutical preparations for the treatment of cancer, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 8, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSMITHKLINE BEECHAM (CORK) LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCOUNTY CORK
IE

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiddlesex UB6 0NN
GB

Trademark Events


Event DateEvent Description
Friday, April 8, 2011CANCELLED SEC. 8 (6-YR)
Thursday, October 7, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 7, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 19, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 19, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 16, 2005AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Monday, July 11, 2005SEC 7 REQUEST FILED
Monday, July 11, 2005PAPER RECEIVED
Tuesday, September 7, 2004REGISTERED-PRINCIPAL REGISTER
Tuesday, June 15, 2004PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2004NOTICE OF PUBLICATION
Monday, March 29, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 5, 2004Sec. 1(B) CLAIM DELETED
Thursday, February 5, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 5, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 26, 2004NON-FINAL ACTION E-MAILED
Monday, January 26, 2004ASSIGNED TO EXAMINER